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During the past year, several laboratories have developed monoclonal antibod- 
ies reactive with idiotypic-like determinants expressed on human and murine T 
cell clones, lines,  or hybridomas (1-5).  These antibodies are felt to react with 
the antigen  receptors  of these  cells.  Such antibodies  can  mimic  the  effects of 
antigen  by specifically activating the immunizing  T  cell, or,  under appropriate 
circumstances, can specifically block the antigen reactivity of the immunizing T 
cell (2-7). Immunoprecipitates prepared from different cells with such antibodies 
contain  distinct  heterodimers  of  80-90  kilodaltons  (kD)  under  nonreducing 
conditions and two chains of 37-52 kD under reducing conditions (1-7). 
On human cells, another set of molecules, T3, has been associated with such 
putative  T  cell  antigen  receptors.  T3  consists  of at  least  three  noncovalently 
linked  distinct  peptides,  each  of which  has  not  been  shown  to  exhibit  any 
structural  or antigenic  polymorphism (8).  Several observations have suggested 
an association between T3 and the putative antigen receptor:  T3 co-modulates 
with  antigen  receptor  determinants  on  T  cell  clones (2);  the  induction  of an 
unresponsive state in T  cell clones exposed to soluble antigen is accompanied by 
a  diminished  expression of T3 (9);  T3  and receptor binding sites are stoichio- 
metric (10);  immunoprecipitates  of T3,  under  some conditions,  contain  the T 
cell receptor heterodimer in addition to the peptides representing T3 (11); and 
the appearance of T3 during T  cell ontogeny has been linked to the expression 
of antigen  receptor-like molecules on T  cells (12).  Despite these observations, 
however, the role of T3 in this association has not been defined. 
T3 may play a critical role in T  cell activation. Monoclonal antibodies reactive 
with T3 can provide one of the two requisite signals required for T  cell activation 
(13-15). Thus,  such antibodies can induce T  cell activation in a  manner analo- 
gous to that noted with antigen or anti-receptor antibodies. This transmembrane 
activation signal is mediated by an increase in cytoplasmic free calcium (16). The 
studies reported here examined the association between T3 and antigen recep- 
tor-like  molecules expressed on a  functional  human  T  cell line, Jurkat,  using 
mutants of  Jurkat. These studies demonstrate that there appears to be an obligate 
requirement  for the  coexpression of T3  and  the antigen  receptor.  Moreover, 
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the expression of these molecules appears to be required for the activation of 
Jurkat cells by the lectin phytohemagglutinin (PHA)) 
Materials and Methods 
Cells.  An interleukin  2  (IL-2)-producing clone ofJurkat,  E6-1, and mutants of this 
clone (described below) were passaged in RPMI 1640 supplemented with 10% fetal bovine 
serum as previously described (15). CTLL-20, a mouse IL-2-dependent T  cell line, was 
passaged in IL-2-supplemented medium as previously described (15). 
Monoclonal Antibodies.  A monoclonal antibody with specificity for an anugen receptor- 
like  molecule expressed on Jurkat  was  derived  from a  fusion  between  SP-2/0  mouse 
myeloma cells and spleen cells from BALB/c mice that had been immunized intraperito- 
neally  with  5  x  l0  s Jurkat  cells  every month  for  3  mo.  The  fusion  was  performed 
according to previously described methods 3 d  after an intravenous immunization with 
the same number of  Jurkat cells (17). One hybrid, C305, proved to be specifically reactive 
with Jurkat. Culture supernatant fluid or ascitic fluid from this hybridoma was used for 
the studies described in this report. Another antibody derived from this fusion, C373, 
proved to be reactive with the proteins associated with the E rosette receptor on human 
T  cells, based on its T  cell specificity, ability to inhibit E rosette formation, and immuno- 
precipitation  of a  55  kD  peptide  on  T  cells.  Both  C305  and  C373  are  IgM  kappa 
immunoglobulins. OKT3, anti-Leu-4, 64.1, anti-Leu-1, anti-Leu-5, W6]32,  MOPC-195, 
and MOPC-104E (IgM) monocional antibodies were obtained from previously described 
sources (15). 
Preparation of Radioiodinated Cell Surface Proteins.  Iodination of cell surface molecules 
was performed using glucose oxidase catalyzation of the lactoperoxidase technique (18). 
Cells were  lysed at 4.0  x  107/ml  in  ice-cold lysis  buffer containing  1.0%  Nonidet-40 
(Particle Data, Inc., Elmhurst, IL), phenylmethylsulfonyl fluoride (1 raM) and benzamidine 
(1  mM) in 0.01  M Tris-HC1, pH 8.0, and iodoacetamide, 10 mM, in 0.15 M NaC1 (lysis 
buffer). After 30  rain of incubation  at 4°C,  nuclei and large debris were removed by 
centrifugation.  Lysates were  then  precleared  with  formalin-fixed Staphylococcus  aureus 
(Calbiochem-Behring Corp.,  La Jolla,  CA),  centrifuged at  100,000 g  for 30  min,  and 
supernatants were stored at -70°C. 
Characterization  of Radioiodinated  Cell Surface Proteins.  Cell  surface molecules were 
characterized using the immunoisolation technique described by Tamura et al. (19). One- 
dimensional sodium  dodecyl sulfate-polyacrylamide gel  electrophoresis (SDS-PAGE) of 
isolated cell surface proteins was performed on 10% acrylamide slab gels with a discontin- 
uous buffer system according to previously described methods (20). The molecular weight 
standards (Pharmacia Fine Chemicals, Piscataway, N  J) run in parallel lanes were visualized 
using Coomassie Blue staining. 
Diagonal, two-dimensional SDS-PAGE was performed on whole cell lysates or isolated 
proteins under nonreducing conditions in the first dimension using tubes containing a 0.2 
x  10-cm 10% gel with a 0.2 x  1-cm 3% stacking gel. Gels were then equilibrated in SDS 
sample buffer containing  5%  2-mercaptoethanol for 30  min  at  22°C  and  the  second 
dimension  electrophoresis was performed using a  10%  acrylamide slab gel.  Autoradi- 
ographs of the dried gels were visualized using intensifying screens and Kodak XAR-5 
film. 
Derivation  of  Jurkat Mutants.  Mutants of  Jurkat cells were produced by exposing cells 
to ethyl methane sulfonate (EMS)  (Sigma Chemical Co., St. Louis, MO), 200 #g/ml, for 
24 h or to 200 rad of gamma radiation (cesium source). After an additional 5 d of culture, 
1-2 x  106 mutagenized cells were negatively selected with OKT3 (1:100 final dilution) 
or C305 ascitic fluid (1:100 final dilution) and rabbit serum (1:8 final dilution) as a source 
of complement for 60 min at 37°C. This negative selection was performed at least three 
l Abbreviations used in this paper: EMS, ethyl methane sulfonate; IL-2, interleukin  2; MCF, mean 
channel  fluorescence; MHC, major histocompatibility complex; PBL, peripheral  blood monocytes; 
PHA, phytohemagglutinin;  PMA, phorbol myristate  acetate;  SDS, sodium dodecyl sulfate; SDS- 
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times over a 2 wk period. Positive selection of T3- or C305-negative cells was performed 
using  indirect  immunofluorescence and  sorting  negative  cells  by  flow  cytometry as 
previously described (16). Positive selection was always performed by staining the treated 
cells with the same antibody used in the negative selection treatment. Sorted negative 
cells were cloned by limiting dilution. 
Indirect lmmunofluorescence, Flow Cytometric Analysis, and Sorting.  Cells were stained 
with hybridoma supernatants (undiluted) or commercial antibodies followed by fluores- 
ceinated F(ab')2 goat anti-mouse Ig (Cappel  Laboratories, Cochranville, PA) as previously 
described  (15).  Cell  were analyzed and  sorted  sterilely on  a  FACS  IV  fluorescence- 
activated cell sorter (Becton, Dickinson & Co, Sunnyvale, CA) according to previously 
described methods (16). 
Quantitative Absorption Studies.  Serial twofold dilutions of cells used for absorptions 
were incubated in 100 #I of OKT3 (1:800) or C305 ascitic fluid (1:I000) for 30 rain at 
22 °C. Supernatants were collected and 50 #i were added to 25 #1 of medium containing 
104 Jurkat cells labeled with ~lCr according to previously described methods (17). To this, 
25 #1 of a  1:8 dilution of rabbit serum that had been preabsorbed with Jurkat cells was 
added. Cells were incubated for 60 min at 37°C and the percent specific ~Cr release was 
determined as previously described (17). 
Stimulation of  Jurkat and Mutants and Determination of lL-2 Activity.  Jurkat or mutant 
cells were stimulated at 1 x  l0  B  cells/ml in microtiter wells as previously described (15). 
The final concentration of the stimulating agents was: PHA (Burroughs Wellcome Co., 
Research Triangle Park, NC),  1 #g/ml; phorbol myristate acetate (PMA) (Sigma Chemical 
Co.), 50 ng/ml; commercial monoclonal antibodies, 1:100 dilution; C305 or C373 hybri- 
doma culture supernatant, 1:20-1:100 dilution; and A23187 (Calbiochem-Behring Corp.), 
1 #g/ml. After 24 h of culture, cell-free supernatants were assessed for IL-2 activity using 
the IL-2-dependent line, CTLL-20, according to previously described methods (15). The 
lower limit of detection in this assay is 2.0 U/ml. 
Results 
Characterization of the Molecules Recognized by Monoclonal Antibody C305.  To 
study  the  association  between  T3  and  the  antigen  receptor,  a  monoclonal 
antibody (C305) reactive with a  putative antigen receptor expressed on the T3- 
positive human T  cell line, Jurkat, was produced. C305 reacted with Jurkat but 
failed to react with B cell lines, peripheral blood lymphocytes (PBL), or other T 
cell lines as assessed by indirect immunofluorescence or antibody and comple- 
ment-mediated  cytotoxicity.  Moreover,  C305  failed  to  react  with  two  other 
available T3-positive human T  cell lines, HUT 78 and PEER. Fig.  1 depicts the 
flow cytometer fluorescent histograms obtained with Jurkat, PBL, and HUT 78 
stained with OKT3 (reactive with T3), C305, and anti-Leu-1 (reactive with T1). 
As  is evident,  C305  appears  to  react  with an  antigenic determinant  uniquely 
expressed on Jurkat. This is contrasted by the histograms obtained with OKT3 
or anti-Leu-1 which reacted with 95% of Jurkat or HUT 78 cells as well as with 
the T  cells within the PBL population. 
The nature of the molecules bearing determinants with which C305  reacted 
were defined by isolation of radioiodinated Jurkat cell surface proteins. By one- 
dimensional  SDS-PAGE,  the  protein  with  which  C305  reacted  migrated  as  a 
diffuse  band  of  80-90  kD  under  nonreducing  conditions  (Fig.  2F).  Under 
reducing conditions, this protein could be resolved into two major peptides of 
42 and 54 kD (Fig. 2,E).  In some studies performed under reducing conditions 
(see below),  a  third band  of intermediate molecular mass has been  visualized, 
perhaps  representing  a  degradation  product  or  an  incompletely  glycosylated WEISS  AND  STOBO  1287 
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FIGURE  1.  C305  reacts  with  idiotypic-like determinants  expressed  on Jurkat.  Shown  are 
fluorescence histograms obtained on a  flow cytometer of Jurkat cells (A-C), PBL (D-F), and 
HUT 78 cells (G-I) stained by indirect immunofluorescence with antibodies of the indicated 
specificities (heavy lines).  In each case,  the  histogram  obtained  with a  nonreactive control 
antibody (light line) is shown for comparison. 
form of the 54  kD band.  Similar observations have been made in the murine 
system (5). Thus, this heterodimer isolated from Jurkat is very similar in molec- 
ular mass to the putative T  cell receptors isolated by others from human T  cell 
clones and lines (1-5). C305 reacts with a molecule distinctly different from T3 
which is represented by the broad band of 22-24  kD and the band of 28  kD 
isolated  from Jurkat  using an  anti-T3  monoclonal antibody (Fig.  2B).  These 
results,  together with  the cell  specificity data,  suggest  that  C305  reacts with 
idiotypic-like determinants expressed on a  heterodimer with structural charac- 
teristics of the putative T  cell antigen receptor. 
C305  Can Activate Jurkat Cells.  Previous studies demonstrated that Jurkat 
cells could be activated to produce IL-2 by PHA (15,  16, 21). This response was 
greatly augmented by the phorbol ester, PMA. Anti-T3 monoclonai antibodies 
could activate Jurkat to produce IL-2, but only if PMA was also added (Table I; 
0  vs.  109  U/mi  of IL-2)  (15).  In  agreement with  previous  results  from this 
laboratory (15),  monoclonal antibodies reactive with T1, T11,  or HLA deter- 
minants failed  to  activate Jurkat  even  in  the  presence of PMA  (Table  I).  A 
monoclonai antibody reactive with an antigen receptor on a responsive cell might 
be expected to function in a manner analogous to antigen by its ability to activate 
the cell. Jurkat  cells could,  indeed, be activated by C305  if PMA  was added 
(Table I). The magnitude of the response to C305 plus PMA was comparable to 
that obtained with OKT3 plus PMA (119 vs.  109 U/ml, respectively). Thus, the 
clonotypic antibody C305,  which has specificity for an 80-90  kD heterodimer, 
could activate Jurkat, supporting the notion that C305  reacts with the antigen 
receptor expressed on Jurkat. 
T3-negative Mutants of  Jurkat Fail to Express the Idiotypic Determinants Recognized 
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FIGURE 2.  C305 reacts with a heterodimer expressed on the surface of Jurkat cells. Cell 
surface molecules  of  Jurkat were iodinated, solubilized  in Nonidet P-40, isolated, and electro- 
phoresed by SDS-PAGE as described in Materials and Methods. Molecules  in lanes A-E and 
F-G were isolated and electrophoresed under reducing and nonreducing conditions, respec- 
tively. Antibodies used for the isolation were as follows: (A) MOPC-195 (IgG), nonreactive 
with  Jurkat; (B) anti-Leu-4, reactive with T3; (C) W6132, reactive with HLA; (D and G) 104E 
(IgM), nonreactive with  Jurkat; (E andF) C305, reactive with the putative antigen receptor 
expressed on Jurkat. 
this laboratory was described. This mutant, S.5, was produced by mutagenization 
with  EMS  followed  by  negative  selection  with  OKT3  and  complement  and 
subsequent  positive selection  of cells lacking T3  by flow cytometry. Since the 
expression of T3 has been associated with the antigen receptor on T  cell clones, 
it was of interest to examine S.5 for the expression of  the determinants recognized 
by C305. 
Initial studies suggested that, indeed, S.5 failed to express antigenic determi- 
nants recognized by C305.  This  was  more  rigorously assessed  in  quantitative 
absorption studies. Whereas the wild-type, T3-bearingJurkat cells absorbed anti- 
T3 antibody activity in a dose-dependent fashion, neither S.5 nor the B cell line 
were able to absorb the anti-T3 activity (Fig.  3A).  From these results it can be 
deduced that S.5 and the B  cell line express <%4th the quantity of T3  that is 
expressed on Jurkat. Similarly, although Jurkat cells were readily able to absorb 
C305 activity, both S.5 and the B cell line failed to absorb C305 (Fig. 3B). These 
results suggest that S.5  not only failed to express detectable T3  determinants 
but also lacked detectable determinants recognized by C305. 
In further studies, depicted in Fig. 4, the specificity of the lack of expression 
of T3  and determinants recognized by C305  on S.5  was examined by indirect 
immunofluorescence as  assessed  by flow cytometry. The  histograms  obtained WEISS  AND  STOBO 
TABLE  I 
C305 Can Activate  Jurkat 
1289 
Antibody  Specificity  Isotype 
IL-2 (U/ml) 
-PMA  +PMA 
OKT3  T3  IgG 2  0  109 +  30.0 
C305  Antigen receptor  IgM  0  119 +  11.1 
Anti-Leu- 1  T 1  IgG 2  0  0 
Anti-Leu-5  T11  IgG 1  0  0 
C373  T11  IgM  0  0 
W6/32  HLA  IgG 2  0  0 
Jurkat cells, 1 X  106/ml, were stimulated with culture supernatants of C305 or 
C373 (1:20 final dilution) or commercial antibodies (1:100 final dilution) in the 
absence or presence of PMA (50 ng/ml) for 24 h. Resultant IL-2 activity in the 
culture supernatants  were assessed as described.  Results represent the mean + 
SEM of three experiments and are expressed as units of IL-2 per milliliter. 
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FIGURE 3.  T3 antigenic determinants and determinants recognized by C305 are lost concom- 
itantly on mutants of  Jurkat as assessed by quantitative absorption.  100 #1 of a  1:800 dilution 
of OKT3 (A) or a  1:1,000 of C305 (B) were absorbed on decreasing numbers of Jurkat (I), 
S.5 (O), J.RT-C305.6 (A), or an EBV-transformed B cell line (A). Residual antibody activity in 
the absorbed supernatants was assessed in an antibody plus complement-mediated assay using 
5tCr-labeled Jurkat cells as described in Materials and  Methods. The dashed  lines represent 
the cytolytic activities of the unabsorbed antibodies. 
with  S.5  cells  stained  with  anti-T3  (Fig.  4F)  or  C305  (Fig.  4G)  monoclonal 
antibodies were not appreciably different than those obtained with the negative 
control antibodies. The fluorescent histograms obtained when S.5 was stained 
with anti-Leu-1 (Fig. 4H, anti-T1), anti-Leu-5 (Fig. 41, anti-T11), and anti-HLA 
(Fig. 4J) demonstrate that S.5, like the wild-type Jurkat cells, express determi- 
nants detected by these antibodies. The inability to detect T3 determinants on 1290  REQUIRED COEXPRESSION OF T3  AND THE  ANTIGEN RECEPTOR 
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FIGURE 4.  Specific  loss of T3 antigenic determinants and determinants recognized by C305 
on mutants ofJurkat. Jurkat (A-E), S.5 (F-J), J.RT-T3.1 (K-O), and J.RT-C305.6 (P-T) were 
assessed for their expression of the indicated antigenic specificities by indirect immunofluo- 
rescence and flow cytometric  analysis (heavy lines). In each case, the histogram obtained with 
a nonreactive control antibody (light line) is shown for comparison. 
S.5 by indirect immunofluorescence was confirmed in previous studies with two 
additional independently derived anti-T3 antibodies, although  the chain(s) with 
which these antibodies react has not been firmly established (16). 
The above results suggested that there might be an obligate requirement for 
the coexpression ofT3 and the antigen receptor. To further examine this notion, 
Jurkat cells were independently mutagenized using either EMS or 7 radiation in 
three separate experiments. An aliquot of cells was then treated with either anti- 
T3 plus complement or C30fi plus complement. Anti-T3-treated cells were then 
selected  for  T3  negativity  and  C305-treated  cells  for  C305  negativity  on  a 
fluorescence-activated  cell  sorter.  Sorted  cells  were  then  cloned  by  limiting 
dilution and screened for the absence of determinants recognized by the antibody 
used in the selection procedure. In four independent mutagenizations, regardless 
of the  mutagen,  or  the  antibody  used  in  the  selection,  every  negative  clone 
analyzed  (n  =  30)  failed  to  express  either  T3  or  the  antigenic  determinants 
recognized  by C305  (summarized  in  Table  II).  For  example, J.RT-C305.6,  a 
radiation-induced  mutant  selected for  its failure  to react  with  C305,  failed to 
express  molecules detected by anti-T3  monoclonal  antibodies.  The  failure  to 
detect  antigenic  determinants  of T3  or  those  recognized  by C305  on J.RT- 
C305.6 was confirmed by quantitative absorption (Fig.  3),  indirect immunoflu- 
orescence (Fig.  4),  and antibody plus complement-mediated  cytotoxicity (data 
not shown).  Similar  results were obtained with the other negative clones listed 
in  Table  II.  These results provide further support for the notion that  T3 and 
the antigen receptor are associated on the plasma membrane. More importantly, 
they suggest an obligate requirement for the coexpression of T3 and the antigen 
receptor. 
In  the  course  of screening  for  T3-negative  mutants,  several  clones  were 
detected that expressed a markedly diminished but not absent level of T3. One WEISS  AND  STOBO  1291 
TABLE  II 
Mutants of  Jurkat Demonstrate an Obligate Requirement for the Coexpression of T3 and the 
Antigen Receptor 
Experi-  Cell  Mutagen 
ment 
Antibody  Relative antigen expression* 
Selection  T3  C305  T1  T11  HLA 
1  S.5  EMS  OKT3 
J.T30.7  EMS  OKT3 
2  J.RT-T3.1  Radiation  OKT3 
J.RT-C305.6  Radiation  C305 
3  J.EMS-T3.3  EMS  OKT3 
J.EMS-C305.1  EMS  C305 
4  J.RT3-T3.5  Radiation  OKT3 
J.RT3.C305.6  Radiation  C305 
_  --  +++  +++  +++ 
+  +  +++  +++  +++ 
B  --  +++  +++  +++ 
--  +++  +++  +++ 
--  +++  +++  +++ 
--  +++  +++  +++ 
--  +++  +++  +++ 
--  +++  +++  +++ 
A summary of the phenotype of the indicated mutants of  Jurkat as assessed by indirect immunoflu- 
orescence/flow cytometry, quantitative absorption, or antibody and complement-mediated cytolysis 
is  presented  (results  represent  at  least  three  separate  assays  for  each  cell). Jurkat  cells were 
mutagenized  with  EMS  (200  t~g/ml)  or  gamma  radiation  and  mutants  were  selected  with  the 
indicated antibody as described in Materials and Methods. 
* The relative antigen expression of the indicated  mutants  was compared with the expression of 
these antigens on the wild-type Jurkat cells, and the density of these antigens on the wild type is 
arbitrarily designated (+++).  A designation of (+) represents an ~ 10-fold decrease in the level of 
detectable antigen assessed by flow cytometry and quantative absorption; (-) indicates the antigen 
was undetectable in any of the three assays. 
such clone, JT30.7  (Table  II), derived by EMS mutagenization and selection 
with  OKT3  plus complement, was  studied in  detail  to  examine the  relative 
density of T3 and determinants detected by C305. Jurkat, J.T30.7, and J.RT- 
T3.1  (a  T3/antigen  receptor-negative  cell  selected  for  T3  negativity after 
radiation-induced mutagenesis) were exposed to saturating quantities of OKT3, 
C305, anti-Leu-5, or W6/32, followed by a fluoresceinated anti-mouse Ig, and 
the relative amounts of bound antibody were assessed by flow cytometric analysis 
(Table III). The mean channel fluorescence (MCF) obtained withJ.T30.7 stained 
with  OKT3  or  C305  (57  and  63,  respectively) were  greater  than  the  MCF 
obtained with the negative control antibody (48) but substantially less than those 
obtained with the wild-type, Jurkat cells (130 and  107, respectively). In other 
words, a mutant that expressed an intermediate density of T3 also expressed an 
intermediate density of determinants detected by C305.  These differences in 
MCF  obtained  with J.T30.7  represent  nearly  a  10-fold  decrease  in  relative 
fluorescence intensity obtained with Jurkat cells stained with OKT3  or C305. 
The MCF of the T3/receptor-negative mutant (J.RT-T3.1) stained with OKT3 
or C305 did not differ from that obtained with MOPC-195, the negative control 
antibody (Table IV). The specificity of the changes in T3 and antigen receptor 
expression noted is demonstrated by the relatively equivalent amounts of T11 
and  HLA  antigens on  all  three  cells  (Table  III).  These results  lend  further 
support to the notion that there is a structural requirement for the coexpression 
of both  T3  and  antigen  receptor  molecules and  suggest  that  they  may  be 
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TABLE  III 
Comparable Decrease in the Density of T3 and Determinants  Detected 
by C305 on Mutants of  Jurkat 
Antibody 
Mean channel fluorescence* 
Jurkat  J.T30.7  J.RT-T3.1 
MOPC-195  48  48  47 
OKT3  130  57  46 
C305  107  63  46 
Anti-Leu-5  138  129  128 
W6/32  156  167  162 
The indicated cells were stained with saturating amounts of the indicated 
monoclonal antibodies followed by a saturating quantity of fluorescein- 
ated anti-mouse Ig. The relative fluorescence of the stained cells was 
determined on a FACS IV flow cytometer. 
* The MCF was determined from the fluorescence histograms obtained 
with the indicated cells prepared with the indicated monoclonal antibod- 
ies. Unimodal distributions were obtained with each cell preparation. A 
10-fold change in relative mean fluorescence intensity would be equiv- 
alent to a change of 57 channels in MCF. 
TABLE  IV 
Ability of Various Stimuli to Activate  T3/Antigen Receptor-negative 
Mutants of  Jurkat 
IL-2 activity (U/ml) 
Stimulus  Responding cell 
Jurkat  S.5  J.RT-T3.1  J.RT-C305.6 
0  0  0  0  0 
PHA  24.1  0  0  0 
PMA  0  0  0  0 
PHA + PMA  172  5.1  0  0 
OKT3 + PMA  79.1  0  0  0 
C305 + PMA  108  0  0  0 
A23187 + PMA  216  98  164  150 
Jurkat or the indicated mutant cells, at 1 x  10S/ml, were cultured in the presence 
of the indicated stimulus for 24 h and the IL-2 activity in the resultant culture 
supernatants were assessed as described in Materials and Methods. Results are 
representative of three separate experiments. 
Failure to Detect Determinants Recognized by C305 on the Antigen Receptor Is Not 
Due to an Altered Epitope.  One alternative explanation for the lack of reactivity 
ofC305  with such mutants is that the C305 antibody recognizes a conformational 
determinant  of the antigen receptor that requires the expression of T3. As such, 
these determinants  might not be expressed on the mutants because the antigen 
receptor  might be present  on  the cell membrane  in an altered conformational 
state. To assess this, whole cell lysates of iodinated cell surface proteins of  Jurkat 
and such mutants were analyzed by diagonal gel electrophoresis. This approach, 
used by others, has demonstrated  that the T  cell antigen receptor is one of only 
a  few  T  cell surface  proteins  with  interchain  disulfide  linkages and,  thus,  falls 
below  the  diagonal  (1).  Note,  whereas  the  individual  chains  of  the  antigen WEISS AND  STOBO  1293 
FIGURE 5.  Antigen receptor molecules are undetectable among the iodinated cell surface 
molecules of T3/antigen receptor-negative mutants ofJurkat, l~-I-labeled  Jurkat cell surface 
molecules isolated with C305 (A) is compared with the iodinated cell surface proteins repre- 
sented in whole cellular lysates of Jurkat (B), S.5 (C), and J.RT-C305.6  (D). SDS-PAGE was 
performed of samples under nonreducing conditions in the first dimension (from left to right) 
followed by reduction and electrophoresis in the second dimension (from top to bottom). 
receptor molecule on Jurkat is demonstrated below the diagonal using the Jurkat 
whole  cell  lysate  (Fig.  5B)  in  a  position  identical  to  the  immunoprecipitate 
prepared with C305 and Jurkat cells (Fig. 5A), no such proteins were detectable 
in either S.5 (Fig. 5 C) orJ.RT-C305.6 (Fig. 5D). These results demonstrate that 
the failure to detect determinants recognized by C305 on these mutants is due 
to the absence of the antigen receptor on the surface of these cells and not due 
to an altered conformation of the antigen receptor. 
Ability of T3 and Antigen Receptor-Negative Mutants To Be Activated by a Variety 
of Stimuli.  Functional studies were performed to assess both the absence of T3 
and the antigen receptor on these mutants of  Jurkat as well as the requirement 
for the  participation  of these  molecules  in  PHA-induced  activation of Jurkat. 1294  REQUIRED  COEXPRESSION  OF  T3  AND  THE  ANTIGEN  RECEPTOR 
Representative results obtained with three of these mutants are compared with 
those obtained  with  the  wild-type Jurkat  cells in  Table  IV.  All  three  mutants 
failed to produce detectable  IL-2  in  response  to either  anti-T3  plus  PMA or 
C305 plus PMA. This is in marked contrast to the response of Jurkat to these 
stimuli (79.1  and  172  U/ml,  respectively). Moreover, these mutants  exhibited 
either  undetectable or markedly diminished  responses to either  PHA alone or 
PHA plus PMA compared with the responses obtained with Jurkat cells (Table 
IV). The low level of IL-2 production by S.5 in response to PHA and PMA has 
been discussed in a previous report (16). The failure of these negative mutants 
to respond to these stimuli could not be attributed to their inability to make IL- 
2.  In  previous studies, Jurkat  and  S.5  cells could be activated by the  calcium 
ionophore A23187 if PMA was also added (16). Responses nearly equivalent to 
those obtained  with  the wild-type Jurkat  cells were observed when any of the 
mutants  were  stimulated  with  A23187  plus  PMA  (Table  IV).  These  results 
strongly  suggest  that  the  expression  of T3  and/or  the  antigen  receptor  are 
required for the activation of Jurkat by the lectin PHA. Moreover, the require- 
ment for T3 and/or the antigen receptor expression can be bypassed by a calcium 
ionophore. 
Discussion 
These  studies  examined  the  association  between T3,  a  set of three  distinct 
polypeptides, and the putative T cell antigen receptor, an 80-90 kD heterodimer, 
expressed on a  human  T  cell line Jurkat.  Anti-T3  and a  monoclonal antibody 
reactive  with  idiotypic-like  determinants  expressed  on  this  putative  antigen 
receptor were used to select mutants of Jurkat that failed to express either T3 
or the antigen receptor.  Regardless of the mutagen used, or the antibody used 
in the selection, all negative mutants failed to express both T3 and such putative 
antigen  receptor  molecules.  Since  four  separate  mutagenizations  were  per- 
formed, a minimum of four independently derived mutants were studied.  In an 
additional mutant,  which expressed a diminished but not absent quantity of T3 
determinants,  the density of antigen receptor determinants was also comparably 
diminished,  suggesting  a  stoichiometric  relation  between T3  and  the  antigen 
receptor.  These  results  extend  those  of others  which  suggest  an  association 
between T3 and the antigen receptor (2, 9-12). They further indicate that there 
is an obligate requirement for the coexpression of T3 and such antigen receptor 
molecules on the surface of T  cells. 
The failure of all of the negative mutants described in this report to express 
both T3  and  the antigen  receptor suggests an  intimate  structural  relationship 
between  these  molecules.  The  most  direct  demonstration  of a  close  spatial 
association between T3 and  the antigen  receptor is provided by the studies of 
Allison and  Lanier  (22).  In  these studies,  a  cross-linking  reagent  with a  12  /k 
span was able to specifically cross-link T3 and the heterodimer expressed on a 
human T  cell tumor as well as similar peptides on a murine T  cell tumor. 
The nature of the mutation in any of the mutants studied in this report is not 
clear. However, it is clear that in each mutant there is a resultant loss of expression 
or comparable decrease in the level of expression of both the antigen receptor 
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loss of expression of both T3 and the antigen receptor: (a) Interaction between 
T3 and the antigen receptor might be required for these molecules to assume 
and  maintain  a  stable  conformation in  the plasma  membrane. This  situation 
might  be  analogous  to  similar  associations  observed  with  other  cell  surface 
molecules. For example, class I major histocompatibility complex (MHC) mole- 
cules are not expressed unless/3~-microglobulin is synthesized (23); immunoglob- 
ulin heavy chains are not expressed on the cell membrane during B cell ontogeny 
until  light  chain  synthesis occurs (24);  and  class  II  MHC  antigen  expression 
requires the expression of both a and fl chains (25). (b) A common regulatory or 
transport  mechanism and/or  some posttranslational  modification may be  re- 
quired for the coexpression of T3 and the antigen receptor. Such a defect could 
account for the observed failure of expression, but it would seem unlikely that 
in several independently derived mutants this transport system would always be 
the target of the mutation. (c) A  common precursor might be involved in the 
synthesis of both T3 and the antigen receptor. Since five polypeptide chains are 
involved, this model seems highly unlikely. (d) The genes encoding both T3 and 
the antigen receptor could be closely linked and, thus, deletion of a large section 
of the genetic material coding for these proteins could result in their concomitant 
loss. Although there are examples of this in the MHC system involving radiation- 
induced mutants,  it  seems unlikely that  independently derived mutants using 
EMS  should  also  result  in  such  extensive loss  of expression  (26).  Given  the 
physical association  that  has been demonstrated between T3  and the antigen 
receptor in previous studies, it would seem that the first alternative of a structural 
requirement for insertion  and  stable  conformation of these molecules in  the 
plasma membrane is the most likely alternative. However, further studies using 
biosynthetic labeling to attempt to isolate any of these proteins that might be 
present in the cytoplasm of these mutants, use of the recently described cDNA 
probes of these genes to examine these mutants for the presence of appropriate 
transcripts, and fusion of mutant cells in complementation studies are required 
to further characterize the nature of the induced mutations. Such studies may 
help define the functional requirement for association between T3 and the T 
cell antigen receptor. 
The requirement for coexpression of T3  and  the antigen receptor on  the 
plasma membrane of Jurkat may also be important in the expression of these 
molecules during thymocyte ontogeny. Although transcripts or even protein of 
the  antigen  receptor  may  be  synthesized  in  many  thymocytes,  cell  surface 
expression of such heterodimers appears to be limited to a minority of thymo- 
cytes, the more functionally mature population that expresses T3 (12, 27,  28). 
In keeping with these observations and the studies reported here, the expression 
of the T  cell antigen receptor may mimic the pattern of differentiation seen in 
B cells; i.e., expression of membrane receptor immunoglobulin does not occur 
until light chain synthesis occurs (24). Thus, although the T  cell antigen receptor 
may be synthesized, cell surface expression is delayed until the synthesis of T3 
occurs. 
PHA and other lectins have been used to activate T  cells.  In general, only 
immunologically competent T  cells respond to such mitogens. PHA and other 
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However, the specific molecules involved in the activation of T  cells by lectins 
have not been defined. The present studies demonstrate that activation of  Jurkat 
by the lectin PHA requires the expression of T3 and/or the antigen receptor, 
suggesting that PHA activates Jurkat, at least in part, by binding to T3 and/or 
the antigen receptor.  Previous studies from this laboratory (16) demonstrated 
that PHA induces an increase in cytoplasmic free calcium in Jurkat but fails to 
induce this change in the T3-negative mutant S.5. These results together with 
the studies reported here suggest that PHA activates Jurkat by binding to T3 
and/or the antigen receptor. 
Recent studies by Moretta et al. (29) have suggested that the antigen recogni- 
tion capacity of T  cell clones could be dissociated from T3  expression. These 
authors  demonstrated  that  if T3  antigen  expression  was  modulated  off of 
ailoreactive  cytolytic T  cell  clones,  some clones  were  still  able  to  recognize 
alloantigens on target cells. However, from the flow cytometer profiles presented 
by these authors, it is clear that responsive, modulated clones have a  markedly 
reduced density of T3  but are not truly T3  negative. In this regard, the data 
obtained with J.T30.7, a clone that expressed ~l/,0th the density of T3/antigen 
receptor  determinants  that  the  wild-type Jurkat  expressed,  is  of relevance. 
Despite the diminished density of T3/antigen receptor determinants on J.T30.7, 
this  cell  was  able  to  be  activated  by  anti-T3,  C305,  or  PHA  plus  PMA  to 
magnitudes comparable to those observed with Jurkat cells (data not presented). 
This was in marked contrast to the absent responses observed with T3/antigen 
receptor-negative mutants. Thus, it would appear that a diminished density of 
T3/antigen receptor expression may be sufficient for full cell activation and may 
help explain the apparent discrepancy between the observations of Moretta et 
al. (29) and those obtained in this report. Furthermore, studies using cells such 
asJ.T30.7 and other mutants with even less T3/antigen receptor expression may 
provide a useful model for examining the minimal number of receptors required 
for cell activation. 
It is clear that T3 and the antigen receptor are associated on the cell surface. 
The functional activity of this complex includes an antigen-binding capacity and 
transmission of one of the transmembrane signals required for T  cell activation. 
This transmembrane signal appears to involve events associated with an increase 
in cytoplasmic free calcium ([Ca++]i) (16). The relative role of T3 or the antigen 
receptor in mediating the effector function involved in generating this transmem- 
brane signal is not clear. Thus, it is not clear whether the antigen receptor alone, 
after  interaction  with  antigen,  can  induce  a  rise  in  [Ca++]i or  whether  an 
interaction with  T3  is  required for the signal  transduction to  occur.  Further 
studies characterizing the relationship of T3 and the antigen receptor through 
the use of mutants, such as those described in this report, may help define the 
relative functions of these molecules in mediating such a transmembrane activa- 
tion signal as well as defining their structural roles required for plasma membrane 
coexpression. 
Summary 
The association between T3  and the T  cell antigen receptor was examined 
using the T3 bearing T  cell leukemic line Jurkat. A monoclonal antibody, C305, WEISS AND  STOBO  1297 
was  produced,  which  reacted  with  idiotypic-like determinants  expressed  on 
Jurkat.  The  molecule with which this antibody reacted was a  disulfide-linked 
heterodimer of 90 kD, composed of polypeptides of 42 and 54 kD. Thus, C305 
reacted with a molecule with characteristics of  the putative T cell antigen receptor 
described by others. A series of mutants of  Jurkat, induced with ethyl methane 
sulfonate or  radiation, was selected for T3  or antigen receptor negativity. In 
every instance, there was a concomitant loss of both T3 and the antigen receptor 
as assessed by quantitative absorption, indirect immunofluorescence, and anti- 
body plus complement-mediated cytotoxicity. The absence of antigen receptor 
molecules was confirmed on diagonal gels, excluding the possibility that confor- 
mational changes of the antigen receptor on  such T3-negative mutants were 
responsible for the failure of such mutants to react with C305.  Moreover, in a 
mutant that expressed a  marked decrease in the level of T3 expression, there 
was a comparable decrease in the expression of antigen receptor determinants. 
These results suggest that there is an obligate requirement for the coexpression 
of T3 and the T  cell antigen receptor. Furthermore, attempts to activate such 
mutants with the lectin phytohemagglutinin suggested that the expression of T3 
and/or the antigen receptor was required for activation of these cells. 
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